Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 31;91(4):e01698-16.
doi: 10.1128/JVI.01698-16. Print 2017 Feb 15.

Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus

Affiliations

Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus

Jason M Schifano et al. J Virol. .

Abstract

The regulation of latency is central to herpesvirus biology. Recent transcriptome-wide surveys have uncovered evidence for promiscuous transcription across the entirety of the Kaposi's sarcoma-associated herpesvirus (KSHV) genome and postulated the existence of multiple viral long noncoding RNAs (lncRNAs). Next-generation sequencing studies are highly dependent on the specific experimental approach and particular algorithms of analysis and therefore benefit from independent confirmation of the results. The antisense-to-latency transcript (ALT) lncRNA was discovered by genome-tiling microarray (Chandriani et al., J Virol 86:7934-7942, 2010, https://doi.org/10.1128/JVI.00645-10). To characterize ALT in detail, we physically isolated this lncRNA by a strand-specific hybrid capture assay and then employed transcriptome sequencing and novel reverse transcription-PCR (RT-PCR) assays to distinguish all RNA species in the KSHV latency region. These methods confirm that ALT initiates at positions 120739/121012 and encodes a single splice site, which is shared with the 3'-coterminal K14-vGPCR/ORF74 mRNA, terminating at 130873 (GenBank accession number GQ994935), resulting in an ∼10,000-nucleotide transcript. No shorter ALT isoforms were identified. This study also identified a novel intron within the LANA 5' untranslated region using a splice acceptor at 127888. In summary, ALT joins PAN/nut1/T1.1 as a bona fide lncRNA of KSHV with potentially important roles in viral gene regulation and pathogenesis.

Importance: Increasing data support the importance of noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and lncRNAs, which have been shown to exert critical regulatory functions without coding for recognizable proteins. Defining the sequences of these ncRNAs is essential for future studies aiming to functionally characterize a specific ncRNA. Most lncRNA studies are highly dependent on high-throughput sequencing and bioinformatic analyses, few studies follow up on the initial predictions, and analyses are at times discordant. The manuscript characterizes one key viral lncRNA, ALT, by physically isolating ALT and by a sequencing-independent assay. It provides for a simple assay to monitor lncRNA expression in experimental and clinical samples. ALT is expressed antisense to the major viral latency transcripts encoding LANA as well as the viral miRNAs and thus has the potential to regulate this key part of the viral life cycle.

Keywords: ALT; KSHV; Kaposi's sarcoma-associated herpesvirus; LANA; RNA enrichment; antisense-to-latency transcripts; gene expression; herpesvirus; latency; lncRNA; long noncoding RNA.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Updated map of known and potential KSHV mRNAs, miRNAs, and lncRNAs. Coordinates of RNA transcripts from the literature were extrapolated to the KSHV strain JSC1 genome (GQ994935.1) and visualized with CLC Bio's Genomics Workbench software. The boundaries of ill-defined lncRNAs have not been determined, and their existence has not been validated. See the .gff file at https://www.med.unc.edu/orfeome/downloads/annotated-target-genomes for a more detailed annotation, including CDS, TSS, pA signals, TTS, repeats, and origins of replication.
FIG 2
FIG 2
Enrichment of human lncRNA MALAT1. (A) Biotinylated antisense oligonucleotides (ASOs; positions marked by dotted lines and numbered as shown in Table 2) and streptavidin-coupled magnetic beads were used to enrich the two major isoforms of lncRNA MALAT1 from TREx BCBL1-RTA cells at 12 h postlytic reactivation. Three amplicons (shaded gray) were used to assess the enrichment of RNA by RT-PCR. The polyadenylation (pA) signal for the minor isoform is marked by a gray vertical line, and the genome-encoded poly(A) tract for the major isoform (86) is marked by a black line. (B) MALAT1 was enriched as detected by all three amplicons (amp), while negative-control RNA GAPDH was not. All samples were run with or without RT. inp, RNA input; cap, ASO-captured RNA.
FIG 3
FIG 3
Schematic of the KSHV latency locus. The latency locus of KSHV was mapped with mRNAs in green and lncRNA ALT in purple. Dotted lines indicate two sets of biotinylated ASOs (numbered as shown in Table 2), one designed to enrich ALT and one to enrich the latency (Lat) transcripts. Shaded blue regions and lines below indicate potential amplicons. Polyadenylation (pA) signals are marked by black lines, and the right origin of lytic replication (ori-LytR) is shown by a dark blue bar.
FIG 4
FIG 4
KSHV lncRNA ALT is expressed during the early lytic stage, and a new splice isoform of a LANA transcript is found. (A) Expression of RNAs during latency or 12 and 24 h postlytic reactivation, as detected by strand- or isoform-specific RT-PCR. The amplicons interrogated are listed above each digital gel image and are illustrated in Fig. 3. (B) Oligonucleotide primers designed for RT-PCR and listed in Table 2 were first tested on BCBL1 genomic DNA. All but the LT2 primers yielded an amplified product from DNA. A short extension time during PCR was intentionally chosen to avoid amplifying a full-length LT2 product from DNA to ensure these primers were specific for the spliced LT2 mRNA. (C) A new splice isoform (LANA new, whose longer 5′ UTR is highlighted in dark green) that contains the LANA CDS (yellow) and is expressed during the lytic stage was identified with an earlier splice acceptor site (blue) than Lat transcript LT1 (5′ UTR in light green). The amino acid sequences of three small peptides encoded by uORFs that are only present in LANA new are shown in gray text below the RNA sequence, while that of LANA is in black text.
FIG 5
FIG 5
ALT is enriched in a strand-specific manner. Strand- and isoform-specific RT-PCR was performed on ALT-captured, Lat-captured, or input RNA using the non-strand-specific primer pair ORF72 (A), negative-control GAPDH (B), the ALT-specific primer pair (C), the Lat-specific LT2 primer pair (D), or the isoform-specific LT1 (E) and K14-ORF74 (F) primer pairs, whose amplicons are illustrated in Fig. 3. ALT was amplified at 12 h postlytic reactivation in ALT-captured but not Lat-captured RNA, while latency transcripts were only amplified in Lat-captured RNA.
FIG 6
FIG 6
Identification of ALT 5′ and 3′ ends using RNA-seq analysis. (A) Strand-specific RNA-seq was performed on ALT-captured RNA from TREx BCBL1-RTA cells at 12 h postlytic reactivation, and reads were aligned to the KSHV strain JSC1 genome using BBMap. Nearly all reads downstream of the common ALT and K14-ORF74 pA signal (orange) contain ≥5 adenine residues starting at position 130873 (GQ994935.1), consistent with published reports, while the remainder span this position in either direction. (B) Reads in the latency locus from the top (blue) and bottom (orange) strands were visualized using Genomics Workbench. Reads align near the published 5′ end of the ALT lncRNA (19).

Similar articles

Cited by

References

    1. Damania B, Cesarman E. 2013. Kaposi's sarcoma-associated herpesvirus, p 2080–2128. In Fields BN, Knipe DM, Howley PM (ed), Fields virology, 6th ed Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA.
    1. Dittmer DP, Damania B. 2013. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)–an update. Curr Opin Virol 3:238–244. doi:10.1016/j.coviro.2013.05.012. - DOI - PMC - PubMed
    1. Kaplan LD. 2013. Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Hematol Am Soc Hematol Educ Program 2013:103–108. - PubMed
    1. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–14867. doi:10.1073/pnas.93.25.14862. - DOI - PMC - PubMed
    1. Chen HS, Wikramasinghe P, Showe L, Lieberman PM. 2012. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency. J Virol 86:9454–9464. doi:10.1128/JVI.00787-12. - DOI - PMC - PubMed

Publication types

LinkOut - more resources